241 related articles for article (PubMed ID: 35320929)
1. Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma.
Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Duan L
Front Mol Biosci; 2021; 8():793732. PubMed ID: 35320929
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Li X; Yuan Y; Pal M; Jiang X
Front Oncol; 2022; 12():929655. PubMed ID: 35719962
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis.
Ren Z; Hu M; Wang Z; Ge J; Zhou X; Zhang G; Zheng H
Front Genet; 2021; 12():672904. PubMed ID: 34434214
[TBL] [Abstract][Full Text] [Related]
4. Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma.
Wang S; Wu C; Ma D; Hu Q
PeerJ; 2021; 9():e11233. PubMed ID: 33954048
[TBL] [Abstract][Full Text] [Related]
5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma.
Ma C; Li F; Luo H
Ann Transl Med; 2021 Jul; 9(13):1058. PubMed ID: 34422970
[TBL] [Abstract][Full Text] [Related]
7. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
Li J; Gu X; Gao C; Zhang J
Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.
Qian L; Wang F; Lu SM; Miao HJ; He X; Feng J; Huang H; Shi RF; Zhang JG
J Immunol Res; 2022; 2022():1951620. PubMed ID: 35509981
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma.
Liu P; Zhou L; Chen H; He Y; Li G; Hu K
PeerJ; 2023; 11():e16242. PubMed ID: 37842058
[TBL] [Abstract][Full Text] [Related]
12. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
[TBL] [Abstract][Full Text] [Related]
13. Identification and verification of a prognostic ferroptosis-related lncRNAs signature for patients with lung adenocarcinoma.
Qi K; Liu XL; Chen XL; Song C; Peng JH; Xu JJ
Am J Transl Res; 2022; 14(6):3698-3715. PubMed ID: 35836852
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma.
Deng B; Xiang J; Liang Z; Luo L
Cancer Cell Int; 2022 Sep; 22(1):292. PubMed ID: 36153508
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma.
Zhang A; Yang J; Ma C; Li F; Luo H
Front Cell Dev Biol; 2021; 9():616271. PubMed ID: 34249899
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression.
Liu Z; Yang S; Zhou S; Dong S; Du J
Cancer Manag Res; 2021; 13():8367-8376. PubMed ID: 34764698
[TBL] [Abstract][Full Text] [Related]
17. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
18. Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma.
Lin W; Chen Y; Wu B; Chen Y; Li Z
Cell Death Discov; 2021 Jun; 7(1):161. PubMed ID: 34226539
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.
Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z
Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413
[TBL] [Abstract][Full Text] [Related]
20. Establishment and Validation of a Ferroptosis-Related Gene Signature to Predict Overall Survival in Lung Adenocarcinoma.
Wang S; Xie Z; Wu Z
Front Genet; 2021; 12():793636. PubMed ID: 35096011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
